180,398 Shares in Cardinal Health, Inc. (NYSE:CAH) Bought by KLP Kapitalforvaltning AS

KLP Kapitalforvaltning AS acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 180,398 shares of the company's stock, valued at approximately $21,336,000. KLP Kapitalforvaltning AS owned about 0.07% of Cardinal Health at the end of the most recent reporting period.

Several other large investors have also modified their holdings of CAH. Cyrus J. Lawrence LLC acquired a new position in Cardinal Health during the fourth quarter worth approximately $26,000. Promus Capital LLC purchased a new stake in shares of Cardinal Health during the 4th quarter valued at $30,000. Lee Danner & Bass Inc. acquired a new stake in shares of Cardinal Health during the 4th quarter worth $35,000. Kentucky Trust Co purchased a new position in shares of Cardinal Health in the 4th quarter worth $41,000. Finally, HHM Wealth Advisors LLC boosted its holdings in Cardinal Health by 57.6% in the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company's stock valued at $47,000 after acquiring an additional 144 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Trading Up 2.2 %

NYSE CAH traded up $2.92 during trading hours on Thursday, reaching $136.90. 2,751,298 shares of the company traded hands, compared to its average volume of 1,978,254. The company has a 50 day moving average of $127.96 and a two-hundred day moving average of $120.48. The stock has a market capitalization of $33.07 billion, a PE ratio of 25.54, a PEG ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a 12 month low of $93.17 and a 12 month high of $139.95.

Remove Ads

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.48%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is presently 37.69%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. JPMorgan Chase & Co. lifted their price objective on Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a research note on Tuesday, February 4th. Citigroup lifted their price target on shares of Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a research report on Friday, January 10th. Morgan Stanley increased their price objective on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a research report on Friday, January 31st. Bank of America upgraded shares of Cardinal Health from a "neutral" rating to a "buy" rating and lifted their target price for the company from $132.00 to $145.00 in a report on Monday, January 6th. Finally, Mizuho started coverage on Cardinal Health in a report on Wednesday, December 4th. They issued an "outperform" rating and a $139.00 price target for the company. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, Cardinal Health currently has a consensus rating of "Moderate Buy" and a consensus price target of $139.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.